Single amino acid mutations, but not common polymorphisms, decrease the activity of CYP1B1 against (-)benzo[a]pyrene-7R-trans-7,8-dihydrodiol
Open Access
- 5 June 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 24 (7) , 1247-1255
- https://doi.org/10.1093/carcin/bgg088
Abstract
Genetic differences that underlie inter-individual variation in the metabolism of common carcinogens are important potential sources of cancer susceptibility. Cytochrome P450 1B1 (CYP1B1), a central enzyme in the activation of the ubiquitous environmental carcinogen benzo[ a ]pyrene (B[ a ]P), has several genetic variants. This study investigated six rare mutations and four common polymorphisms for their effects on B[ a ]P metabolism. Five missense mutations associated with congenital glaucoma (Gly61Glu, Gly365Trp, Asp374Asn, Pro437Leu and Arg469Tryp) dramatically decreased the capacity of CYP1B1 to convert (−)benzo[ a ]pyrene-7R- trans -7,8-dihyrodiol (B[ a ]P-7,8-diol) to (±)benzo[ a ]pyrene-r-7,t-8-dihydrodiol-9,10-epoxides. These five mutations resulted in enzymes with 3–12% of normal activity when assayed in vitro using an Saccharomyces cerevisiae microsomal expression system. A 10 bp deletion mutation produced no detectable protein or activity. In contrast, proteins containing all possible combinations of four common single nucleotide polymorphisms (Arg48Gly, Ala199Ser, Val432Leu, Asn453Ser) had modest effects on B[ a ]P-7,8-diol metabolism. Michaelis–Menten analysis suggested that two alleles, Arg48, Ala119, Val432, Ser453 (RAVS) and Arg48, Ala119, Leu432, Ser453 (RALS), have KM values 2-fold lower than Arg48, Ala119, Val432, Ser453 (RAVN): 1.4 ± 0.3 and 1.3 ± 0.4 µM, respectively, compared with 2.8 ± 0.8 µM ( P < 0.05). However, these differences could not be confirmed with direct measurements of rate at low substrate concentration. There were no significant differences for either of two other kinetic parameters, kcat or kcat / KM . Allele frequency analysis in three populations reveals the Ser453 variant is rare among those of Asian (a ]P-7,8-diol; however, our results do not identify any major differences in this metabolism due to four common single amino acid polymorphisms.Keywords
This publication has 27 references indexed in Scilit:
- Polycyclic aromatic hydrocarbons in the dietMutation Research - Genetic Toxicology and Environmental Mutagenesis, 1999
- Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1Carcinogenesis: Integrative Cancer Research, 1998
- Isolation and Characterization of the Human Cytochrome P450 CYP1B1 GeneJournal of Biological Chemistry, 1996
- The role of 12 cDNA‐expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans‐7, 8‐dihydrodiolMolecular Carcinogenesis, 1994
- Binding and metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene by seven purified forms of cytochrome P-450Carcinogenesis: Integrative Cancer Research, 1984
- Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes.Physiological Reviews, 1980
- Enzymatic conversion of benzo(a)pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene through a single enantiomer of r-7, t-8-dihydroxy-7,8-dihydrobenzo(a)pyrene.Proceedings of the National Academy of Sciences, 1976
- Exceptional mutagenicity of a benzo[a]pyrene diol epoxide in cultured mammalian cellsNature, 1976
- High mutagenicity and toxicity of a diol epoxide derived from benzo[a]pyreneBiochemical and Biophysical Research Communications, 1976
- Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells.Proceedings of the National Academy of Sciences, 1976